Abstract
Provided herein are synthetic P. vivax antigens, antibodies and pharmaceutical formulations and vaccines thereof. Also provided herein are methods of treating and/or preventing Plasmodium infection and/or disease by administering the synthetic P. vivax antigens, antibodies and pharmaceutical formulations and vaccines thereof.
| Original language | English |
|---|---|
| Patent number | US12404311B2 |
| IPC | C07K14/445 Plasmodium |
| Priority date | 23/09/19 |
| Filing date | 23/09/19 |
| Publication status | Published - 2 Sept 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Plasmodium
- Antigens
- Antibodies
- Pharmaceutical formulations
- Vaccines
Fingerprint
Dive into the research topics of 'Synthetic plasmodium antigens, compositions, and uses thereof'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver